Detected ·
Specific Biologics
$35M—
Toronto-based Specific Biologics, developing gene-editing therapy for ALS, raised US$35M from investors including Lumira Ventures.
- Website
- www.specificbiologics.com
- linkedin.com/company/18991581
- Amount
- $35 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-11-03 04:10:43 UTC
- Signal ID
- c2b8e817-f011-4742-91cb-7f3537818347
As the API returns it
{
"id": "c2b8e817-f011-4742-91cb-7f3537818347",
"created_at": "2026-11-03T04:10:43.575140Z",
"company_name": "Specific Biologics",
"company_website_url": "www.specificbiologics.com",
"company_linkedin_url": "https://www.linkedin.com/company/18991581",
"event_type": "funding",
"funding_amount": 35000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Toronto-based Specific Biologics, developing gene-editing therapy for ALS, raised US$35M from investors including Lumira Ventures.*"
}